← Leaderboards
Timothy Jensen Henrich
University Of California, San Francisco
$17,762,972
Attributed
$30,174,834
Total exposure
18
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12.2M · FY2012–25$20M$15M$10M$5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$30,174,834 · 18
By mechanism
R01$18,963,215 · 6
RM1$2,331,737 · 1
R21$2,298,247 · 5
U01$2,255,898 · 1
R33$1,192,233 · 1
R61$983,744 · 1
Top collaborators
- Utkan Demirci8 shared
- Henry F. Vanbrocklin7 shared
- Zian H Tseng6 shared
- Priscilla Y. Hsue5 shared
- Emanual M. Maverakis3 shared
- Kathryn Elaine Stephenson2 shared
- Amelia N Deitchman1 shared
- Sulggi Angela Lee1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Annesa Flentje$4,561,730
- Emanual M. Maverakis$6,125,352
- Zian H Tseng$15,934,925
- Catherine Anne Stimets Koss$3,514,120
- Amelia N Deitchman$1,849,448
Others in their field
Top investigators on “Viral”
- Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
- David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
- Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
- Judith S. Currier · University Of California Los Angeles$185,434,785
- Constance Ann Benson · University Of California, San Diego$165,517,633
Research focus
ViralInfectionCellsTissuesAntiretroviral TherapyInsightHiv-1Cd4 Positive T LymphocytesCohortSamplingVirusImmuneInnovationResidual StateGenetic TranscriptionBloodHiv InfectionsMorbidity - Disease RateIn VivoLeadParticipantPeripheral BloodLymph NodesPeripheral Blood Mononuclear Cell
Grant awards (50)
Multimodal PET-CT imaging of SIVmac239 dynamics post-ART interruption$3,302,677
R01 · FY2025 · AI
Immune Activation and Region-specific Myocardial Arrhythmic Substrate in Sudden Cardiac Death Victims with HIV$3,264,423
R01 · FY2025 · HL
In Vivo Imaging and Post-Mortem Study of Methamphetamine Use on Immune Dysfunction and HIV Reservoir Transcription among People with HIV on ART$2,331,737
RM1 · FY2025 · DA · contact PI
Whole Body Deep Tissue Characterization of the Human Virome$1,127,949
U01 · FY2025 · AT · contact PI
HIV Reservoir and Gene Modified Cell Dynamics Following Autologous Stem Cell Transplantation$781,939
R01 · FY2025 · AI · contact PI
In Vivo PET Imaging of HIV Infection$735,024
R01 · FY2025 · AI · contact PI
In situ spatial characterization of CNS HIV-host cellular interactions from victims of sudden death$491,908
R61 · FY2025 · DA · contact PI
Mentoring Scientists for Careers in HIV Translational Clinical Research$191,388
K24 · FY2025 · AI · contact PI
Whole Body Deep Tissue Characterization of the Human Virome$1,127,949
U01 · FY2024 · AT · contact PI
HIV Reservoir and Gene Modified Cell Dynamics Following Autologous Stem Cell Transplantation$804,996
R01 · FY2024 · AI · contact PI
In Vivo PET Imaging of HIV Infection$736,856
R01 · FY2024 · AI · contact PI
In situ spatial characterization of CNS HIV-host cellular interactions from victims of sudden death$491,836
R61 · FY2024 · DA · contact PI
Mentoring Scientists for Careers in HIV Translational Clinical Research$191,388
K24 · FY2024 · AI · contact PI
HIV Reservoir and Gene Modified Cell Dynamics Following Autologous Stem Cell Transplantation$803,309
R01 · FY2023 · AI · contact PI
In situ and digital spatial profiling of the active HIV reservoir in autopsy-derived tissues$497,145
P01 · FY2023 · AI · contact PI
Mentoring Scientists for Careers in HIV Translational Clinical Research$191,388
K24 · FY2023 · AI · contact PI
In Vivo PET Imaging of HIV Infection$737,195
R01 · FY2022 · AI · contact PI
Targeting Non Viral Markers of HIV Persistence$622,821
R01 · FY2022 · AI · contact PI
In situ and digital spatial profiling of the active HIV reservoir in autopsy-derived tissues$405,205
P01 · FY2022 · AI · contact PI
In Vivo PET Imaging of HIV Infection$738,002
R01 · FY2021 · AI · contact PI
Longitudinal Immunological Impact of SARS-CoV-2 Infection$736,876
R01 · FY2021 · AI · contact PI
Targeting Non Viral Markers of HIV Persistence$677,623
R01 · FY2021 · AI · contact PI
Longitudinal Immunological Impact of SARS-CoV-2 Infection$743,919
R01 · FY2020 · AI · contact PI
In Vivo PET Imaging of HIV Infection$731,949
R01 · FY2020 · AI · contact PI
Targeting Non Viral Markers of HIV Persistence$703,510
R01 · FY2020 · AI · contact PI
Targeting Non Viral Markers of HIV Persistence$677,215
R01 · FY2019 · AI · contact PI
Single Cell Characterization of Latent HIV-1 Reservoirs$318,077
R01 · FY2019 · AI · contact PI
Biomarkers of CNS HIV Persistence$240,563
R21 · FY2019 · MH · contact PI
Targeting Non Viral Markers of HIV Persistence$702,932
R01 · FY2018 · AI · contact PI
Single Cell Characterization of Latent HIV-1 Reservoirs$382,515
R01 · FY2018 · AI · contact PI
Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin$365,246
R33 · FY2018 · AI · contact PI
Biomarkers of CNS HIV Persistence$199,844
R21 · FY2018 · MH · contact PI
Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin$403,568
R33 · FY2017 · AI · contact PI
Single Cell Characterization of Latent HIV-1 Reservoirs$378,588
R01 · FY2017 · AI · contact PI
Measurement of Antibody Epitope Signatures by Peptide Microarrays to Determine Recency of HIV Infection$248,605
R21 · FY2017 · AI
Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin$423,419
R33 · FY2016 · AI · contact PI
Single Cell Characterization of Latent HIV-1 Reservoirs$382,769
R01 · FY2016 · AI · contact PI
Measurement of Antibody Epitope Signatures by Peptide Microarrays to Determine Recency of HIV Infection$225,055
R21 · FY2016 · AI
Impact of Chemotherapy and Stem Cell Transplant on HIV-1 Reservoir Dynamics$121,366
K23 · FY2016 · AI · contact PI
A Novel Microfluidic HIV-1 Co-Culture Assay to Quantify Latent Reservoirs$253,875
R21 · FY2015 · AI · contact PI
Microfluidic PCR Method to Identify and Characterize HIV-Infected Single Cells$247,779
R21 · FY2015 · AI · contact PI
Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin$205,651
R21 · FY2015 · AI · contact PI
Impact of Chemotherapy and Stem Cell Transplant on HIV-1 Reservoir Dynamics$73,685
K23 · FY2015 · AI · contact PI
Impact of Chemotherapy and Stem Cell Transplant on HIV-1 Reservoir Dynamics$64,285
K23 · FY2015 · AI · contact PI
A Novel Microfluidic HIV-1 Co-Culture Assay to Quantify Latent Reservoirs$226,235
R21 · FY2014 · AI · contact PI
Microfluidic PCR Method to Identify and Characterize HIV-Infected Single Cells$226,201
R21 · FY2014 · AI · contact PI
Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin$224,439
R21 · FY2014 · AI · contact PI
Impact of Chemotherapy and Stem Cell Transplant on HIV-1 Reservoir Dynamics$137,970
K23 · FY2014 · AI · contact PI
Impact of Chemotherapy and Stem Cell Transplant on HIV-1 Reservoir Dynamics$137,970
K23 · FY2013 · AI · contact PI
Impact of Chemotherapy and Stem Cell Transplant on HIV-1 Reservoir Dynamics$137,970
K23 · FY2012 · AI · contact PI